Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tromethamine API
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A.forall Launches CGT-Exclusive Tromethamine Injection in US
Details : Tromethamine act as a proton acceptor and prevents or corrects acidosis, administered by intravenous infusion, into the ventricular cavity during cardiac arrest.
Product Name : THAM Solution
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 30, 2025
Lead Product(s) : Tromethamine API
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable